David Steinberg
Stock Analyst at Jefferies
(2.80)
# 1,646
Out of 4,814 analysts
36
Total ratings
57.14%
Success rate
17.86%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Steinberg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BHC Bausch Health Companies | Downgrades: Hold | $12 → $8 | $4.60 | +74.10% | 7 | Feb 6, 2025 | |
| PRGO Perrigo Company | Upgrades: Buy | $45 → $63 | $25.37 | +148.32% | 8 | Sep 30, 2021 | |
| SUPN Supernus Pharmaceuticals | Upgrades: Buy | $25 → $40 | $30.78 | +29.95% | 11 | Apr 13, 2021 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $151 → $188 | $102.02 | +84.28% | 5 | Oct 9, 2020 | |
| OCUL Ocular Therapeutix | Initiates: Buy | $8 | $7.34 | +8.99% | 1 | Mar 17, 2020 | |
| SCPH scPharmaceuticals | Maintains: Buy | $26 → $12 | $2.57 | +366.93% | 2 | Jun 14, 2018 | |
| OPTN OptiNose | Initiates: Buy | $405 | $9.17 | +4,316.58% | 1 | Nov 7, 2017 | |
| SVRA Savara | Initiates: Buy | $20 | $3.01 | +565.56% | 1 | Sep 22, 2017 |
Bausch Health Companies
Feb 6, 2025
Downgrades: Hold
Price Target: $12 → $8
Current: $4.60
Upside: +74.10%
Perrigo Company
Sep 30, 2021
Upgrades: Buy
Price Target: $45 → $63
Current: $25.37
Upside: +148.32%
Supernus Pharmaceuticals
Apr 13, 2021
Upgrades: Buy
Price Target: $25 → $40
Current: $30.78
Upside: +29.95%
Jazz Pharmaceuticals
Oct 9, 2020
Maintains: Buy
Price Target: $151 → $188
Current: $102.02
Upside: +84.28%
Ocular Therapeutix
Mar 17, 2020
Initiates: Buy
Price Target: $8
Current: $7.34
Upside: +8.99%
scPharmaceuticals
Jun 14, 2018
Maintains: Buy
Price Target: $26 → $12
Current: $2.57
Upside: +366.93%
OptiNose
Nov 7, 2017
Initiates: Buy
Price Target: $405
Current: $9.17
Upside: +4,316.58%
Savara
Sep 22, 2017
Initiates: Buy
Price Target: $20
Current: $3.01
Upside: +565.56%